Creasallis

Creasallis is a biopharmaceutical company that develops antibody therapeutics, specifically for cancer treatment. Their CreaTap technology is designed to enhance the penetration of antibody-based drugs into solid tumors.

CreaTap technology
Monoclonal antibodies
Bispecific antibodies
IP management services
Antibody drug conjugates
Protein and peptide conjugates

Size

Small

Phone

N/A

Website

creasallis.com

N/A

Locations

babraham research park, CB22 3AT

07957933599

Digital Popularity

Social Media

LinkedIn
1,659 Followers

Competitors

Cell Guidance Systems

Cell Guidance Systems develops innovative products and services that enhance human health and support scientific research.

Stemnovate

Stemnovate is a pioneering company focused on building animal models for drug discovery in the pharmaceutical and animal health industries.

Domainex

Domainex is a leading integrated drug discovery services provider that collaborates with life science organisations to accelerate the development of new medicines.

Company Details

Creasallis is operated by Creasallis Ltd and is a Active company incorporated on 15 June 2021 with the registered office located in Cambridge, Cambridgeshire. Creasallis Ltd was registered 4 years ago.

Status

Active

Size

Micro

Directors

Age

4 years old

Employees

Turnover

Unreported

Total Assets

£365.96K